Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase

被引:43
|
作者
Sonar, Vijay P. [1 ]
Corona, Angela [2 ]
Distinto, Simona [1 ]
Maccioni, Elias [1 ]
Meleddu, Rita [1 ]
Fois, Benedetta [1 ]
Floris, Costantino [3 ]
Malpure, Nilesh V. [4 ]
Alcaro, Stefano [5 ]
Tramontano, Enzo [2 ]
Cottiglia, Filippo [1 ]
机构
[1] Univ Cagliari, Drug Sci Sect, Dept Life & Environm Sci, Via Osped 72, I-09124 Cagliari, Italy
[2] Univ Cagliari, Dept Life & Environm Sci, Cittadella Monserrato SS554, I-09042 Cagliari, Italy
[3] Univ Cagliari, Dipartimento Sci Chim, I-09042 Cagliari, Italy
[4] SSGM Coll, Dept Bot, IN-423601 Kopargaon, MS, India
[5] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Campus S Venuta,Viale Europa, I-88100 Catanzaro, Italy
关键词
Ocimum sanctum; HIV-1; RNase H; Reverse transcriptase; Triterpenes; Ferulic acid derivatives; RIBONUCLEASE H ACTIVITY; MOLECULAR-MECHANICS; BINDING-AFFINITY; ACTIVE-SITE; RNASE-H; DERIVATIVES; IDENTIFICATION; PARAMETERS; RECEPTORS; DISCOVERY;
D O I
10.1016/j.ejmech.2017.02.054
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using an HIV-1 Reverse Transcriptase (RT)-associated RNase H inhibition assay as lead, bioguided fractionation of the dichloromethane extract of the Ocimum sanctum leaves led to the isolation of five triterpenes (1-5) along with three 3-methoxy-4-hydroxy phenyl derivatives (6-8). The structure of this isolates were determined by 1D and 2D NMR experiments as well as ESI-MS. Tetradecyl ferulate (8) showed an interesting RNase H IC50 value of 12.4 mu M and due to the synthetic accessibility of this secondary metabolite, a structure-activity relationship study was carried out. A series of esters and amides of ferulic and caffeic acids were synthesized and, among all, the most active was N-oleylcaffeamide displaying a strong inhibitory activity towards both RT-associated functions, ribonuclease H and DNA polymerase. Molecular modeling studies together with Yonetani-Theorell analysis, demonstrated that Noleylcaffeamide is able to bind both two allosteric site located one close to the NNRTI binding pocket and the other close to RNase H catalytic site. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:248 / 260
页数:13
相关论文
共 50 条
  • [31] Structure based activity prediction of HIV-1 reverse transcriptase inhibitors
    de Jonge, MR
    Koymans, LMH
    Vinkers, HM
    Daeyaert, FFD
    Heeres, J
    Lewi, PJ
    Janssen, PAJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2176 - 2183
  • [32] Synthesis of certain heterodimers expected as HIV-1 reverse transcriptase inhibitors
    Ladurée, D
    Sugeac, E
    Fossey, C
    Schmidt, S
    Laumond, G
    Aubertin, AM
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (5-8): : 873 - 875
  • [33] HIV-1 reverse transcriptase inhibitors: Drug resistance and drug development
    Sluis-Cremer, Nicolas
    Ross, Ted
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (15) : 1809 - 1810
  • [34] Pyrophosphate analogs as inhibitors of phosphorolytic activity of HIV-1 reverse transcriptase
    Yanvarev, D.
    Smirnova, O.
    Ivanov, A.
    Tatarintsev, A.
    Kukhanova, M.
    FEBS JOURNAL, 2009, 276 : 352 - 353
  • [35] QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Duchowicz, Pablo R.
    Fernandez, Michael
    Caballero, Julio
    Castro, Eduardo A.
    Fernandez, Francisco M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 5876 - 5889
  • [36] Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
    Moreno, S
    Casado, JL
    Pérez-Elias, MI
    Dronda, F
    Antela, A
    Moreno, A
    Gutiérrez, C
    AIDS, 2003, 17 (09) : 1413 - 1414
  • [37] Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors
    Patel, M
    McHugh, RJ
    Cordova, BC
    Klabe, RM
    Bacheler, LT
    Erickson-Viitanen, S
    Rodgers, JD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1943 - 1945
  • [38] Synthesis and evaluation of quinolinones as HIV-1 reverse transcriptase inhibitors.
    Patel, M
    McHugh, RJ
    Cordova, BC
    Klabe, RM
    Erickson-Viitanen, S
    Rodgers, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U20 - U20
  • [39] The role of nonnucleoside reverse transcriptase inhibitors for the treatment of HIV-1 infection
    Wang, Qian
    Zheng, Yong-Tang
    Chinese Pharmaceutical Journal, 2002, 37 (12) : 881 - 884
  • [40] SYNTHESIS AND EVALUATION OF NOVEL INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE
    LYLE, TA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 27 - ORGN